Human Procarboxypeptidase U, or Thrombin-activable Fibrinolysis Inhibitor, Is a Substrate for Transglutaminases
Open Access
- 1 October 1998
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 273 (42), 27220-27224
- https://doi.org/10.1074/jbc.273.42.27220
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- On the Mechanism of the Antifibrinolytic Activity of Plasma Carboxypeptidase BJournal of Biological Chemistry, 1997
- Functional Characterization of Recombinant Human Meizothrombin and Meizothrombin(desF1)Journal of Biological Chemistry, 1997
- TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin ComplexPublished by Elsevier ,1996
- Plasma carboxypeptidases as regulators of the plasminogen system.Journal of Clinical Investigation, 1995
- Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis InhibitorJournal of Biological Chemistry, 1995
- Characterization of the binding of plasminogen to fibrin surfaces: The role of carboxy-terminal lysinesBiochemistry, 1991
- Role of cell-surface lysines in plasminogen binding to cells: identification of .alpha.-enolase as a candidate plasminogen receptorBiochemistry, 1991
- α2-antiplasmin's carboxy-terminal lysine residue is a major site of interaction with plasminBiochemical and Biophysical Research Communications, 1988
- Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.Journal of Clinical Investigation, 1988
- C‐terminal lysine residues of fibrinogen fragments essential for binding to plasminogenFEBS Letters, 1985